Related Experiment Video
Updated: Mar 19, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Dramatic Response of Topical Doxycycline in Umbilical Granuloma: Report of 84 Cases
Huaijie Wang1, Ya Gao1, Yitao Duan1
1Second Affiliated Hospital, Medical College of Xi'an JiaoTong University, Xi'an, China.
Abstract:
We previously observed that topical doxycycline powder was effective in the treatment of umbilical granuloma. This study aims to evaluate the efficacy of this agent. The patients were randomly assigned into inpatient group and outpatient group. Doxycycline powder was administered topically once daily for 5 days. The protocol was restarted if no response observed. Eighty-four patients were included in this study. With one course of therapy, the overall cure rate was 82.14% (69/84), and the statistical difference in response rate was not significant between the 2 groups (P > .05). With 2 courses of therapy, the overall cure rate was 94.05% (79/84). No complication was observed during treatment. No recurrence was observed during follow-up. The treatment of umbilical granuloma using topical doxycycline is safe and efficacious. The administration of the agent can be performed conveniently by parents at home. This protocol could be considered to be the first treatment option for this disorder in neonates and infants.
Insights
Topical doxycycline powder effectively treats umbilical granuloma in infants. This safe and convenient home treatment offers high cure rates, making it a potential first-line option.
Area of Science:
- Neonatal care
- Dermatology
- Pediatric infectious diseases
Background:
- Umbilical granuloma is a common neonatal condition.
- Previous studies indicated topical doxycycline's effectiveness.
Purpose of the Study:
- To evaluate the efficacy and safety of topical doxycycline powder for umbilical granuloma treatment.
- To compare inpatient versus outpatient treatment groups.
Main Methods:
- Eighty-four neonates and infants with umbilical granuloma were randomly assigned to inpatient or outpatient groups.
- Topical doxycycline powder was applied once daily for 5 days, with potential for a second course if needed.
Main Results:
- A single course of therapy achieved an 82.14% cure rate.
- Two courses of therapy increased the overall cure rate to 94.05%.
- No significant difference in response rates was observed between inpatient and outpatient groups (P > .05).
Conclusions:
- Topical doxycycline powder is a safe and effective treatment for umbilical granuloma.
- The treatment is convenient for home administration by parents.
- This protocol is a viable first-line treatment option for neonates and infants.
Related Concept Videos
Acne Infection
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Hand hygiene
Hand washing...

